Search Result
Results for "
L-leucine
" in MedChemExpress (MCE) Product Catalog:
3
Biochemical Assay Reagents
22
Isotope-Labeled Compounds
Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-N0486
-
-
-
- HY-N0486R
-
leucine (Standard)
|
Reference Standards
mTOR
Endogenous Metabolite
|
Metabolic Disease
|
L-Leucine (Standard) is the analytical standard of L-Leucine. This product is intended for research and analytical applications. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-W002303
-
-
-
- HY-N0486S
-
-
-
- HY-N0486S12
-
-
-
- HY-N0486S9
-
-
-
- HY-137946
-
|
Aminopeptidase
|
Others
|
L-Leucine 4-methoxy-β-naphthylamide hydrochloride is an aminopeptidase M and leucine aminopeptidase substrate .
|
-
-
- HY-W419440
-
L-leucine, L-lysyl-
|
Biochemical Assay Reagents
|
Others
|
H-Lys-Leu-OH (L-Leucine, L-lysyl-) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
-
-
- HY-N0486S11
-
-
-
- HY-N0486S4
-
-
-
- HY-N0486S1
-
-
-
- HY-N0486S3
-
-
-
- HY-N0486S10
-
-
-
- HY-N0486S5
-
-
-
- HY-N0486S2
-
-
-
- HY-N0486S8
-
-
-
- HY-N0486S6
-
|
mTOR
Endogenous Metabolite
|
Metabolic Disease
|
L-Leucine-2- 13C, 15N is the 13C- and 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S7
-
|
mTOR
Endogenous Metabolite
|
Metabolic Disease
|
L-Leucine-1- 13C, 15N is the 13C- and 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-W557739
-
-
-
- HY-N0486S13
-
-
-
- HY-137844
-
Leu-AMC hydrochloride
|
Fluorescent Dye
|
Others
|
L-Leucine-7-amido-4-methylcoumarin (Leu-AMC) hydrochloride is a bright blue fluorogenic peptidyl substrate for LAP3 (leucine aminopeptidase). L-Leucine-7-amido-4-methylcoumarin hydrochloride can be used for leucine aminopeptidase inhibition assays in vitro .
|
-
-
- HY-79415
-
-
-
- HY-79404
-
L-leucine, N-[(1,1-dimethylethoxy)carbonyl]-4-methyl- (9CI); (S)-2-(tert-Butoxycarbonylamino)-4,4-dimethylpentanoic acid
|
Amino Acid Derivatives
|
Others
|
N-(Tert-Butoxycarbonyl)-L-neopentylglycine is a Glycine (HY-Y0966) derivative .
|
-
-
- HY-169826
-
|
Biochemical Assay Reagents
|
Others
|
N-Lithocholyl-L-Leucine is a bile acid conjugate composed of Lithocholic acid (HY-B0172) and L-leucine (HY-N0486). N-Lithocholyl-L-Leucine can be used to form hydrogels .
|
-
-
- HY-128434
-
-
-
- HY-113221
-
-
-
- HY-129905
-
LLOMe hydrochloride; Leu-Leu methyl ester hydrochloride; H-Leu-Leu-OMe hydrochloride
|
Endogenous Metabolite
|
Inflammation/Immunology
|
L-Leucyl-L-Leucine methyl ester (LLOMe) hydrochloride, a dipeptide condensation product of L-leucine methyl ester generated by human monocytes or polymorphonuclear leukocytes, selectively eliminates lymphocytes with cytotoxic potential. L-Leucyl-L-Leucine methyl ester hydrochloride also can induce endolysosomal pathway stress .
|
-
-
- HY-113221R
-
|
Reference Standards
Proteasome
Endogenous Metabolite
|
Metabolic Disease
|
Isovalerylcarnitine (Standard) is the analytical standard of Isovalerylcarnitine. This product is intended for research and analytical applications. Isovalerylcarnitine is a product of the catabolism of L-leucine. Isovalerylcarnitine is also a selective and reversible calpain activator that induces apoptosis .
|
-
-
- HY-129905A
-
LLOMe hydrobromide; Leu-Leu methyl ester hydrobromide; H-Leu-Leu-OMe hydrobromide
|
Endogenous Metabolite
|
Inflammation/Immunology
|
L-Leucyl-L-Leucine methyl ester (LLOMe) hydrobromide, a dipeptide condensation product of L-leucine methyl ester generated by human monocytes or polymorphonuclear leukocytes, selectively eliminates lymphocytes with cytotoxic potential. L-Leucyl-L-Leucine methyl ester hydrobromide also can induce endolysosomal pathway stress .
|
-
-
- HY-122811
-
-
-
- HY-W016077
-
-
-
- HY-W046352
-
-
-
- HY-W068839
-
-
-
- HY-W009686
-
-
-
- HY-W016077R
-
|
Reference Standards
Endogenous Metabolite
|
Others
|
Glycyl-L-leucine (Standard) is the analytical standard of Glycyl-L-leucine. This product is intended for research and analytical applications. Glycyl-l-leucine is a dipeptide that can be a common substrate for glycyl-leucine dipeptidase.
|
-
-
- HY-W142035
-
-
-
- HY-Y0555
-
-
-
- HY-W101499
-
|
Biochemical Assay Reagents
|
Others
|
L-a-Aspartyl-L-leucine is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
-
-
- HY-59291
-
N-Acetyl-L-leucine
|
Amino Acid Derivatives
|
Neurological Disease
Metabolic Disease
Inflammation/Immunology
|
Levacetylleucine (N-acetyl-L-leucine), an orally bioavailable and brain-penetrant compound, is an acetylated derivative of amino acid Leucine. Levacetylleucine is the active form of N-acetyl-leucine (NAL). Levacetylleucine attenuates neuronal death and neuroinflammation in the cortical tissue of mice. Levacetylleucine also potentially improves ameliorates lysosomal and metabolic dysfunction. Levacetylleucine improves compensation of postural symptoms after unilateral chemical labyrinthectomy (UL) in rats. Levacetylleucine is promising for research of neurological manifestations of Niemann-Pick disease type C, traumatic brain injury and neurodegeneration prevention .
|
-
-
- HY-N14218
-
-
-
- HY-W101495
-
N-Boc-L-leucine monohydrate
|
Amino Acid Derivatives
|
Others
|
Boc-Leu-OH hydrate (N-Boc-L-leucine monohydrate) is an amino acid derivative with a Boc protecting group, which can be used to synthesize L-prolyl-L-leucyl-glycinamide peptide, a peptide mimetic with dopamine receptor modulatory activity .
|
-
-
- HY-W008642
-
L-Leucyl-L-leucine
|
Amino Acid Derivatives
|
Metabolic Disease
|
Leu-Leu-OH (L-Leucyl-L-leucine), a Leu derivative, is a neutral dipeptide that can be used to study the functionality of dileucine motifs .
|
-
-
- HY-W037451
-
|
Amino Acid Derivatives
|
Others
|
Methyl L-leucinate, methyl ester of L-leucine, is an alpha-amino acid ester. Methyl L-leucinate is a derivative of methyl ester and L-leucine, a class of compounds containing both amino and carboxyl groups in the molecule .
|
-
-
- HY-W040088
-
-
-
- HY-43459
-
-
-
- HY-78008
-
-
-
- HY-Y0378
-
(R)-leucine
|
Endogenous Metabolite
|
Neurological Disease
|
D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro .
|
-
-
- HY-W340583S
-
-
-
- HY-Y0378S
-
(R)-leucine-d10
|
Isotope-Labeled Compounds
Endogenous Metabolite
|
Neurological Disease
|
D-Leucine-d10 is the deuterium labeled D-Leucine. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro .
|
-
-
- HY-W012708
-
|
Endogenous Metabolite
|
Others
|
3-Amino-4-methylpentanoic acid is a β amino acid and positional isomer of L-leucine which is naturally produced in humans via the metabolism of L-leucine by the enzyme leucine 2,3-aminomutase. 3-Amino-4-methylpentanoic acid is also a metabolite produced by Torulaspora delbrueckii and can be used in the research of wine fermentation .
|
-
- HY-145542
-
-
- HY-Y0378R
-
(R)-leucine (Standard)
|
Reference Standards
Endogenous Metabolite
|
Neurological Disease
|
D-Leucine (Standard) is the analytical standard of D-Leucine. This product is intended for research and analytical applications. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro .
|
-
- HY-I0616A
-
|
Drug Intermediate
|
Others
|
(S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-acetyl-L-leucine is a drug intermediate for synthesis of various active compounds.
|
-
- HY-I0591
-
-
- HY-W654243
-
-
- HY-145542S
-
|
Proteasome
Endogenous Metabolite
|
Metabolic Disease
|
Isovalerylcarnitine-d9 (chloride) is the deuterium labeled Isovalerylcarnitine (chloride) . Isovalerylcarnitine chloride, a product of the catabolism of L-leucine, is a potent activator of the Ca2+-dependent proteinase (calpain) of human neutrophils .
|
-
- HY-145542R
-
|
Proteasome
Endogenous Metabolite
|
Metabolic Disease
|
Isovalerylcarnitine (chloride) (Standard) is the analytical standard of Isovalerylcarnitine (chloride). This product is intended for research and analytical applications. Isovalerylcarnitine chloride, a product of the catabolism of L-leucine, is a potent activator of the Ca2+-dependent proteinase (calpain) of human neutrophils .
|
-
- HY-128434R
-
|
Reference Standards
Endogenous Metabolite
|
Metabolic Disease
|
L-Leucyl-L-alanine (Standard) is the analytical standard of L-Leucyl-L-alanine (HY-128434). This product is intended for research and analytical applications. L-Leucyl-L-alanine is a simple aliphatic dipeptide composed of L-leucine and L-alanine .
|
-
- HY-W002299
-
Boc-D-Leu-OH hydrate
|
Amino Acid Derivatives
|
Neurological Disease
|
Boc-D-Leucine monohydrate (Boc-D-Leu-OH hydrate) is an N-Boc-protected form of D-Leucine. D-Leucine is an unnatural isomer of L-Leucine that acts as an auto-inhibitor of lactic streptococci. D-Leucine shows potent anti-seizure effect .
|
-
- HY-W002291
-
4-Fluoro-L-phenylalanine
|
Biochemical Assay Reagents
|
Others
|
p-Fluoro-L-phenylalanine (4-Fluoro-L-phenylalanine) is a substrate for tyrosine hydroxylase (TH) that can be used to study the regulation of that enzyme. p-Fluoro-L-phenylalanine binds to the L-leucine specific receptor of Escherichia coli (KD=0.26 μM) .
|
-
- HY-P2768
-
LDH, EC 1.4.1.9
|
Endogenous Metabolite
|
Metabolic Disease
|
Leucine dehydrogenase, Microorganism (EC 1.4.1.9) can be purified from Bacillus spheroides. Leucine dehydrogenase catalyzed the oxidative deamination of L-leucine, L-valine, L-isoleucine, L-norvaline, L-alpha-aminobutyrate, and L-norleucine, and the reductive amination of their keto analogues .
|
-
- HY-W269700S
-
L-Isoleucyl-L-leucine-13C6,15N
|
Isotope-Labeled Compounds
|
Metabolic Disease
|
Ile-(Leu-13C6,15N)-OH (TFA) is 13C- and 15N-labeled L-Isoleucyl-L-leucine (HY-W269700). L-Isoleucyl-L-leucine has a role as a metabolite and can be used to inhibit movement-induced muscle damage and muscle defective condition.
|
-
- HY-W008642S
-
L-Leucyl-13C6,15N-L-leucine
|
Isotope-Labeled Compounds
|
Others
|
(Leu-13C6,15N)-Leu-OH TFA is a C13 and N15 labeled Leu-Leu-OH TFA. Leu-Leu-OH, a Leu derivative, is a dipeptide .
|
-
- HY-137872
-
|
Biochemical Assay Reagents
|
Others
|
L-Leucyl-4-nitroanilide hydrochloride is a commonly used substrate in various biochemical assays to measure the activity of enzymes that cleave peptide bonds, such as proteases. L-Leucine p-nitroanilide hydrochloride has unique chemical properties that allow it to be cleaved by these enzymes to form a yellow product called p-nitroaniline. This makes it a useful tool for detecting and quantifying protease activity in biological samples such as blood or tissue extracts.
|
-
- HY-W700927
-
-
- HY-W012722BS
-
α-Ketoisocaproic acid-d7 sodium
|
Endogenous Metabolite
Isotope-Labeled Compounds
|
Neurological Disease
Metabolic Disease
|
4-Methyl-2-oxopentanoic acid-d7 (α-Ketoisocaproic acid-d7) sodium is the deuterium labeled 4-Methyl-2-oxopentanoic acid (HY-W012722).4-Methyl-2-oxopentanoic acid is a metabolite of L-leucine and is involved in energy metabolism. 4-Methyl-2-oxopentanoic acid increases endoplasmic reticulum stress, promotes lipid accumulation in preadipocytes and insulin resistance by impairing mTOR and autophagy signaling pathways .
|
-
- HY-W012722
-
α-Ketoisocaproic acid
|
Endogenous Metabolite
Autophagy
mTOR
SOD
|
Neurological Disease
Metabolic Disease
|
4-Methyl-2-oxopentanoic acid (α-Ketoisocaproic acid) is a metabolite of L-leucine and is involved in energy metabolism. 4-Methyl-2-oxopentanoic acid increases endoplasmic reticulum stress, promotes lipid accumulation in preadipocytes and insulin resistance by impairing mTOR and autophagy signaling pathways. 4-Methyl-2-oxopentanoic acid also causes oxidative damage, leading to cognitive deficits, inhibits α-ketoglutarate dehydrogenase activity, acts as an oxidative phosphorylation uncoupler and metabolic inhibitor. 4-Methyl-2-oxopentanoic acid acts as a nutrient signal and stimulates skeletal muscle protein synthesis. 4-Methyl-2-oxopentanoic acid can be used in the study of maple syrup urine disease .
|
-
Cat. No. |
Product Name |
Type |
-
- HY-137844
-
Leu-AMC hydrochloride
|
Fluorescent Dyes/Probes
|
L-Leucine-7-amido-4-methylcoumarin (Leu-AMC) hydrochloride is a bright blue fluorogenic peptidyl substrate for LAP3 (leucine aminopeptidase). L-Leucine-7-amido-4-methylcoumarin hydrochloride can be used for leucine aminopeptidase inhibition assays in vitro .
|
Cat. No. |
Product Name |
Type |
-
- HY-W002291
-
4-Fluoro-L-phenylalanine
|
Biochemical Assay Reagents
|
p-Fluoro-L-phenylalanine (4-Fluoro-L-phenylalanine) is a substrate for tyrosine hydroxylase (TH) that can be used to study the regulation of that enzyme. p-Fluoro-L-phenylalanine binds to the L-leucine specific receptor of Escherichia coli (KD=0.26 μM) .
|
-
- HY-137872
-
|
Enzyme Substrates
|
L-Leucyl-4-nitroanilide hydrochloride is a commonly used substrate in various biochemical assays to measure the activity of enzymes that cleave peptide bonds, such as proteases. L-Leucine p-nitroanilide hydrochloride has unique chemical properties that allow it to be cleaved by these enzymes to form a yellow product called p-nitroaniline. This makes it a useful tool for detecting and quantifying protease activity in biological samples such as blood or tissue extracts.
|
-
- HY-W557739
-
Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-W002303
-
-
- HY-79415
-
-
- HY-79404
-
L-leucine, N-[(1,1-dimethylethoxy)carbonyl]-4-methyl- (9CI); (S)-2-(tert-Butoxycarbonylamino)-4,4-dimethylpentanoic acid
|
Amino Acid Derivatives
|
Others
|
N-(Tert-Butoxycarbonyl)-L-neopentylglycine is a Glycine (HY-Y0966) derivative .
|
-
- HY-W212029
-
-
- HY-128434
-
-
- HY-122811
-
-
- HY-W046352
-
-
- HY-W068839
-
-
- HY-W009686
-
-
- HY-137946
-
|
Aminopeptidase
|
Others
|
L-Leucine 4-methoxy-β-naphthylamide hydrochloride is an aminopeptidase M and leucine aminopeptidase substrate .
|
-
- HY-W142035
-
-
- HY-Y0555
-
-
- HY-W101495
-
N-Boc-L-leucine monohydrate
|
Amino Acid Derivatives
|
Others
|
Boc-Leu-OH hydrate (N-Boc-L-leucine monohydrate) is an amino acid derivative with a Boc protecting group, which can be used to synthesize L-prolyl-L-leucyl-glycinamide peptide, a peptide mimetic with dopamine receptor modulatory activity .
|
-
- HY-W008642
-
L-Leucyl-L-leucine
|
Amino Acid Derivatives
|
Metabolic Disease
|
Leu-Leu-OH (L-Leucyl-L-leucine), a Leu derivative, is a neutral dipeptide that can be used to study the functionality of dileucine motifs .
|
-
- HY-W037451
-
|
Amino Acid Derivatives
|
Others
|
Methyl L-leucinate, methyl ester of L-leucine, is an alpha-amino acid ester. Methyl L-leucinate is a derivative of methyl ester and L-leucine, a class of compounds containing both amino and carboxyl groups in the molecule .
|
-
- HY-43459
-
-
- HY-78008
-
-
- HY-P4384
-
|
Peptides
|
Others
|
H-Leu-Ser-OH is a dipeptide formed from L-leucine and L-serine residues and is a metabolite .
|
-
- HY-I0591
-
-
- HY-P4383
-
|
Peptides
|
Others
|
H-Leu-Leu-Ala-OH is a tripeptide composed of two L-leucine units joined to L-alanine by a peptide linkage. H-Leu-Leu-Ala-OH shows antioxidant activities .
|
-
- HY-128434R
-
|
Reference Standards
Endogenous Metabolite
|
Metabolic Disease
|
L-Leucyl-L-alanine (Standard) is the analytical standard of L-Leucyl-L-alanine (HY-128434). This product is intended for research and analytical applications. L-Leucyl-L-alanine is a simple aliphatic dipeptide composed of L-leucine and L-alanine .
|
-
- HY-W002299
-
Boc-D-Leu-OH hydrate
|
Amino Acid Derivatives
|
Neurological Disease
|
Boc-D-Leucine monohydrate (Boc-D-Leu-OH hydrate) is an N-Boc-protected form of D-Leucine. D-Leucine is an unnatural isomer of L-Leucine that acts as an auto-inhibitor of lactic streptococci. D-Leucine shows potent anti-seizure effect .
|
Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
Cat. No. |
Product Name |
Chemical Structure |
-
- HY-N0486S
-
|
L-Leucine-d10 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S12
-
|
L-Leucine-d2 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S9
-
|
L-Leucine-d3 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S1
-
|
L-Leucine- 13C is the 13C-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S3
-
|
L-Leucine- 15N is the 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S2
-
|
Leucine- 13C6 is the 13C-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S11
-
|
L-Leucine-d is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S4
-
|
L-Leucine-d7 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S10
-
|
L-Leucine- 18O2 is the 18O-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S5
-
|
L-Leucine-2- 13C is the 13C-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S8
-
|
L-Leucine- 13C6, 15N is the 13C- and 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S6
-
|
L-Leucine-2- 13C, 15N is the 13C- and 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S7
-
|
L-Leucine-1- 13C, 15N is the 13C- and 15N-labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-N0486S13
-
|
L-Leucine- 15N,d10 is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
-
-
- HY-W340583S
-
|
(2-(1H-indol-3-yl)acetyl)-L-leucine-d4 is deuterium labeled (2-(1H-indol-3-yl)acetyl)-L-leucine .
|
-
-
- HY-Y0378S
-
|
D-Leucine-d10 is the deuterium labeled D-Leucine. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro .
|
-
-
- HY-W654243
-
|
Isovalerylcarnitine-d9-1 (chloride) is deuterium labeled Isovalerylcarnitine (chloride). Isovalerylcarnitine chloride, a product of the catabolism of L-leucine, is a potent activator of the Ca 2+-dependent proteinase (calpain) of human neutrophils .
|
-
-
- HY-145542S
-
|
Isovalerylcarnitine-d9 (chloride) is the deuterium labeled Isovalerylcarnitine (chloride) . Isovalerylcarnitine chloride, a product of the catabolism of L-leucine, is a potent activator of the Ca2+-dependent proteinase (calpain) of human neutrophils .
|
-
-
- HY-W269700S
-
|
Ile-(Leu-13C6,15N)-OH (TFA) is 13C- and 15N-labeled L-Isoleucyl-L-leucine (HY-W269700). L-Isoleucyl-L-leucine has a role as a metabolite and can be used to inhibit movement-induced muscle damage and muscle defective condition.
|
-
-
- HY-W008642S
-
|
(Leu-13C6,15N)-Leu-OH TFA is a C13 and N15 labeled Leu-Leu-OH TFA. Leu-Leu-OH, a Leu derivative, is a dipeptide .
|
-
-
- HY-W700927
-
|
N-Formyl-L-leucine-d3 (N-Formyl-S-leucine-d3) is deuterium labeled N-Formyl-L-leucine. N-Formyl-L-leucine is a leucine derivative .
|
-
-
- HY-W012722BS
-
|
4-Methyl-2-oxopentanoic acid-d7 (α-Ketoisocaproic acid-d7) sodium is the deuterium labeled 4-Methyl-2-oxopentanoic acid (HY-W012722).4-Methyl-2-oxopentanoic acid is a metabolite of L-leucine and is involved in energy metabolism. 4-Methyl-2-oxopentanoic acid increases endoplasmic reticulum stress, promotes lipid accumulation in preadipocytes and insulin resistance by impairing mTOR and autophagy signaling pathways .
|
-
Cat. No. |
Product Name |
|
Classification |
-
- HY-N0486
-
leucine
|
|
Others
|
L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway .
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: